Law360 (May 22, 2020, 3:02 PM EDT) – A Latham & Watkins LLP-advised Chinese biopharmaceutical company raised $15 million to continue its research on a vaccine for the coronavirus.

Sinovac Biotech Ltd. announced Friday that its subsidiary received two $7.5 million convertible loans from Chinese private equity funds Advantech Capital and Vivo Capital to continue the development of its CoronaVac vaccine.

https://www.law360.com/articles/1276244/latham-led-biopharma-co-gets-15m-for-covid-19-vaccine